Updated:
G1 Therapeutics, Inc.
G1 Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001560241, and its reported industry...
Overview
G1 Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001560241, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-02-28, it reported annual revenue of USD 82,511,000; net income of USD -47,967,000; total assets of USD 121,540,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- G1 Therapeutics, Inc.
- Former names in filing history
- G-Zero Therapeutics, Inc. (2012-10-12 to 2013-04-18)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Research Triangle Park, NC, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001560241
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2023USD | $82.5M | -$48.0M | $121.5M | $32.2M | -$38.3M | |
| FY2022USD | $51.3M | -$147.6M | $188.0M | $94.6M | -$128.6M | |
| FY2021USD | $31.5M | -$148.4M | $254.1M | $221.2M | -$132.1M | |
| FY2020USD | $45.3M | -$99.3M | $228.6M | $207.3M | -$83.7M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| SC 13G | — | Form SC 13G | |
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A | ||
| 8-K | 8-K | ||
| 10-K | 10-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research G1 Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.